MedPath

四川汇宇海玥医药科技有限公司

Ownership
-
Established
2019-05-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

Polymyxin B Sulfate for Injection

Product Name
注射用硫酸多粘菌素B
Approval Number
国药准字H20254318
Approval Date
May 27, 2025
NMPA

Carbazochrome Sodium Sulfonate Injection

Product Name
卡络磺钠注射液
Approval Number
国药准字H20254077
Approval Date
May 13, 2025
NMPA

Carbazochrome Sodium Sulfonate Injection

Product Name
卡络磺钠注射液
Approval Number
国药准字H20254078
Approval Date
May 13, 2025
NMPA

Thiotepa for Injection

Product Name
塞替派注射液
Approval Number
国药准字H20253532
Approval Date
Mar 4, 2025
NMPA

Thiotepa for Injection

Product Name
塞替派注射液
Approval Number
国药准字H20253533
Approval Date
Mar 4, 2025
NMPA

Amifostine For Injection

Product Name
注射用氨磷汀
Approval Number
国药准字H20249418
Approval Date
Nov 22, 2024
NMPA

Methocarbamol Injection

Product Name
美索巴莫注射液
Approval Number
国药准字H20249006
Approval Date
Sep 26, 2024
NMPA

Famotidine Injection

Product Name
法莫替丁注射液
Approval Number
国药准字H20244386
Approval Date
Jul 9, 2024
NMPA

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20244135
Approval Date
Jun 25, 2024
NMPA

Nimodipine Injection

Product Name
尼莫地平注射液
Approval Number
国药准字H20243969
Approval Date
Jun 11, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.